All survival assays were conducted by clustering patients into the high- and low-BMP4 groups according to the median expression of BMP4. As a result, the OS, DFS, and PFS of PAAD were significantly shorter with high BMP4 expressions, while the DSS was unaffected (Figures 1D–G). The gene discussed is BMP4; the disease is pancreatic adenocarcinoma.